Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
about
Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled TrialsThe EEG as an index of neuromodulator balance in memory and mental illnessEvaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack Provocation.Exercise reverses the effects of early life stress on orexin cell reactivity in male but not female rats.Appetitive associative learning recruits a distinct network with cortical, striatal, and hypothalamic regions.Motivational activation: a unifying hypothesis of orexin/hypocretin functionA selective orexin-1 receptor antagonist attenuates stress-induced hyperarousal without hypnotic effectsRecruitment of hypothalamic orexin neurons after formalin injections in adult male rats exposed to a neonatal immune challenge.Acid-base dysregulation and chemosensory mechanisms in panic disorder: a translational updateMetabolic and behavioral effects of mutant huntingtin deletion in Sim1 neurons in the BACHD mouse model of Huntington's disease.Novel approaches for the treatment of psychostimulant and opioid abuse - focus on opioid receptor-based therapies.Phase II Proof-of-Concept Trial of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Major Depressive Disorder.Orexin/hypocretin neuron activation is correlated with alcohol seeking and preference in a topographically specific manner.An integrated modelling framework for neural circuits with multiple neuromodulators.New directions for the treatment of depression: Targeting the photic regulation of arousal and mood (PRAM) pathway.Opportunities and perspectives for developing orexin receptor antagonists.A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?Synthesis and Evaluation of Orexin-1 Receptor Antagonists with Improved Solubility and CNS Permeability.Neuropharmacology of compulsive eating.The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders.
P2860
Q26796379-6ECE2B8D-5821-4272-85D0-A0D49F142FADQ30439431-EB71021B-D486-4B80-8CC3-FD0FECB5E6F1Q33780634-9AE97329-B791-4A3A-AC9A-3BBC5C50633EQ33938054-77064D84-FFD2-4B90-8D6C-6763661E0C6EQ34982959-7CF7DC75-DCCA-4748-AACE-4C5FBCCC86A3Q35105241-D4EDAED4-F196-4BF5-B1AA-552232402E9EQ35156407-06765DB2-C079-41EA-ABB0-2F0D3F4C7FF4Q35161170-3FB0237B-25EC-4197-AB86-895FB7126621Q35753229-A41A1105-AA7E-4772-973F-475A92A00320Q36059260-FFA25235-2BDA-444F-84D7-B3DADC44D0E8Q36104010-DB09E519-66E3-48B5-979D-41A328B51294Q38743165-98E70618-7A6D-4AB1-97AA-FAC8EB506FCAQ38849902-C17281F6-7FE5-415A-9A2D-BFF06668FB95Q39013683-690D8E20-CEC8-43F0-B0BB-37DD6C2BC906Q39295637-65F1AE9C-03C6-42EE-8C2D-15E091ACC76BQ40609526-F058FB48-31A2-4D1C-B012-88D080567067Q46514264-DD1F22A0-E46A-4B90-98E1-2F57B3927EDEQ47307899-59D04F02-2A88-43A8-84E5-BC8AAC15E6B6Q52315306-CB6B4A01-4462-405C-867F-CA2EEA95D0C1Q52316130-A559EAB2-E791-4733-94CD-025257CE2725
P2860
Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
@ast
Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
@en
Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
@nl
type
label
Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
@ast
Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
@en
Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
@nl
prefLabel
Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
@ast
Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
@en
Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
@nl
P2860
P50
P3181
P356
P1476
Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
@en
P2093
Jiann Wei Yeoh
P2860
P3181
P356
10.3389/FNINS.2014.00036
P407
P577
2014-02-25T00:00:00Z